These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 29230217)

  • 21. Activation of the Wnt Pathway by
    Villaseñor T; Madrid-Paulino E; Maldonado-Bravo R; Urbán-Aragón A; Pérez-Martínez L; Pedraza-Alva G
    Front Immunol; 2017; 8():50. PubMed ID: 28203237
    [No Abstract]   [Full Text] [Related]  

  • 22. [A view of dynamics of immune responses against tuberculosis infection through QFT].
    Harada N
    Kekkaku; 2011 Jul; 86(7):743-9. PubMed ID: 21922785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection.
    Court N; Vasseur V; Vacher R; Frémond C; Shebzukhov Y; Yeremeev VV; Maillet I; Nedospasov SA; Gordon S; Fallon PG; Suzuki H; Ryffel B; Quesniaux VF
    J Immunol; 2010 Jun; 184(12):7057-70. PubMed ID: 20488784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunology of tuberculosis and cytokines].
    Tsuyuguchi I
    Kekkaku; 1995 May; 70(5):335-46. PubMed ID: 7783394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis.
    Tailleux L; Pham-Thi N; Bergeron-Lafaurie A; Herrmann JL; Charles P; Schwartz O; Scheinmann P; Lagrange PH; de Blic J; Tazi A; Gicquel B; Neyrolles O
    PLoS Med; 2005 Dec; 2(12):e381. PubMed ID: 16279841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunotherapy for MDR-TB (multi-drug resistant tuberculosis)--its feasibility].
    Tsuyuguchi I
    Kekkaku; 1999 Jun; 74(6):479-91. PubMed ID: 10423959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TB or not TB: that is no longer the question.
    Modlin RL; Bloom BR
    Sci Transl Med; 2013 Nov; 5(213):213sr6. PubMed ID: 24285487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung necrosis and neutrophils reflect common pathways of susceptibility to Mycobacterium tuberculosis in genetically diverse, immune-competent mice.
    Niazi MK; Dhulekar N; Schmidt D; Major S; Cooper R; Abeijon C; Gatti DM; Kramnik I; Yener B; Gurcan M; Beamer G
    Dis Model Mech; 2015 Sep; 8(9):1141-53. PubMed ID: 26204894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection.
    Caccamo N; Guggino G; Joosten SA; Gelsomino G; Di Carlo P; Titone L; Galati D; Bocchino M; Matarese A; Salerno A; Sanduzzi A; Franken WP; Ottenhoff TH; Dieli F
    Eur J Immunol; 2010 Aug; 40(8):2211-20. PubMed ID: 20540114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB.
    Marín ND; París SC; Rojas M; García LF
    Tuberculosis (Edinb); 2013 Mar; 93(2):155-66. PubMed ID: 23332142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium tuberculosis and dendritic cells: recognition, activation and functional implications.
    Sinha A; Salam N; Gupta S; Natarajan K
    Indian J Biochem Biophys; 2007 Oct; 44(5):279-88. PubMed ID: 18341202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of tuberculosis.
    Gupta UD; Katoch VM
    Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection.
    Dorhoi A; Reece ST; Kaufmann SH
    Immunol Rev; 2011 Mar; 240(1):235-51. PubMed ID: 21349097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity in tuberculosis.
    Chaparas SD
    Bull World Health Organ; 1982; 60(4):447-62. PubMed ID: 6814775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.